Ovarian Cancer Diagnostics And Therapeutics Market – 2019-2025
Market Overview
Ovarian cancer is the fifth most common cause of cancer deaths in women, globally, and the tenth most common cancer among women in the United States. The incidences of ovarian cancer are high in women aged 55-64 years.
The major symptoms of ovarian cancer include bloating, pelvic and abdominal pain, difficulty in eating, and urinary symptoms. According to the US Census Bureau, women above 60 years of age account for almost 57% of all ovarian cancer incidences and 75% of all ovarian cancer related deaths worldwide, with a median age at diagnosis being 63 years and the median age at death being 70 years. Thus, the increasing geriatric population is driving the growth of the ovarian cancer diagnostics and therapeutics market. An accurate diagnosis for ovarian cancer is critical, as in most cases, cancer already begins to spread to the lymph nodes and outside of the pelvis at the time of diagnosis.
Ovariancancerawareness.org reports that the five-year survival rate for ovarian cancer with early stage 1 detection is 93% and that most new cases of ovarian cancer are diagnosed at stage 3 or later, leaving little time as well as room for an accurate diagnosis
Get Sample Report PDF >>
The following manufacturers are covered:
Astrazeneca
Boehringer Ingelheim
Bristol Myers Squibb
Eli Lilly
F. Hoffman-La Roche
Glaxosmithkline
Johnson & Johnson
Kazia Therapeutics
Siemens Healthineers
MSD
Clovis Oncology
Pfizer
Merck
Scope of the Report
Ovarian cancer is a type of cancer that begins in the ovaries. There are several types of ovarian cancer, Epithelial ovarian cancer is the most common type of ovarian cancer. The report covers four major types of ovarian cancer namely epithelial ovarian tumors, ovarian germ cell tumors, and others. As per the scope of the report, other ovarian cancer types are covered in these four segments. For example, epithelial ovarian tumors cover cancer types such as primary peritoneal cancer and fallopian tube cancer which are similar to epithelial ovarian cancer and are treated and diagnosed in similar ways.
Market segment by Type, the product can be split into
Diagnosis
Therapeutics
Market segment by Application, split into
Hospital
Medical Research Institute
Pharmaceuticals Companies
Other
This report provides comprehensive analysis of
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs
Browse Report »
Key Market Trends
CT Scan Segment is Expected to Register Robust Growth
Computed Tomography (CT) is an imaging procedure that uses special X-ray equipment to create detailed pictures, or scans, of areas inside the body. It is also called computerized tomography and computerized axial tomography (CAT). These equipment do not show small ovarian tumors well, but they can see larger tumors, and may be able to see if the tumor is growing into nearby structures. It can also find the enlarged lymph nodes, signs of cancer spread to liver or other organs, or signs that an ovarian tumor is affecting the kidneys or bladder.
United States is Expected to Retain Largest Market Share During the Period of Forecast.
Among the North American region, the United States holds the highest share in the ovarian cancer diagnostics and therapeutics market and has contributed majorly for the same. Ovarian cancer is the ninth most common cancer and the fifth leading cause of cancer death among women in the United States. A woman’s lifetime risk of developing ovarian cancer is about one in 73 in the country. Most of the top global ovarian cancer diagnostics players are headquartered in the United States and this tends to be the major advantage for the region. High prevalence in the region and the rising incidence of an aging population are the factors that drive the market.
Competitive Landscape
Key players in the market include AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffman-La Roche Ltd, GlaxoSmithKline Plc, Johnson and Johnson, Kazia Therapeutics, and Siemens Healthineers among others.
Customization of the Report
- Value chain analysis
- Consumer behavior analysis at country level
The report includes six parts, dealing with:
1.) basic information;
2.) the Asia Ovarian Cancer Diagnostics and Therapeutics Speaker Market;
3.) the North American Ovarian Cancer Diagnostics and Therapeutics Speaker Market;
4.) the European Ovarian Cancer Diagnostics and Therapeutics Speaker Market;
5.) market entry and investment feasibility;
6.) the report conclusion.
Table of Content:
1 Study Coverage
2 Executive Summary
3 Breakdown Data by Manufacturers
4 Breakdown Data by Type
5 Breakdown Data by Application
…
11 Company Profiles
12 Future Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
14 Value Chain and Sales Channels Analysis
15 Research Findings and Conclusion
16 Appendix
The key insights of The report Research:
1.The report Research provides key statistics on the market status of the Ovarian Cancer Diagnostics and Therapeutics manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
2.The report Research provides a basic overview of the industry including its definition, applications and manufacturing technology.
3.The report Research presents the company profile, product specifications, capacity, production value, and 2019-2018 market shares for key vendors.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report Research estimates 2019-2025 market development trends of Ovarian Cancer Diagnostics and Therapeutics industry.
6.Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out
7.The report Research makes some important proposals for a new project of Ovarian Cancer Diagnostics and Therapeutics Industry before evaluating its feasibility.
Reasons to Purchase this Report:
* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Continued …
About Us:
“Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Spanning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories”.
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
Sales@Wiseguyreports.Com
Http://Www.Wiseguyreports.Com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
